Literature DB >> 3469166

Treatment of genital chlamydial infection with ofloxacin.

L Fransen, D Avonts, P Piot.   

Abstract

42 men and women with a genital chlamydial infection were randomly treated with a single dose of 200 mg doxycycline daily for ten days or with 200 mg ofloxacin twice a day for nine days. Two weeks after starting treatment 40 patients were able to be reassessed. All 12 men and all seven women treated with doxycycline had clinically improved or healed and had negative cultures for Chlamydia trachomatis. Among the patients treated with ofloxacin, all 11 males had improved or healed and C. trachomatis was not reisolated. These data are promising but larger numbers of patients and a longer follow-up are needed in order to confirm the efficacy of ofloxacin for the treatment of genital chlamydial infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3469166     DOI: 10.1007/BF01661307

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  A culture medium for Trichomonas vaginalis donné and species of Candida.

Authors:  J G FEINBERG; M J WHITTINGTON
Journal:  J Clin Pathol       Date:  1957-11       Impact factor: 3.411

Review 2.  Chlamydial infections (second of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-03-02       Impact factor: 91.245

3.  Quinolones--a paradoxical adolescence.

Authors: 
Journal:  Lancet       Date:  1986-04-12       Impact factor: 79.321

4.  Identification of Gardnerella (Haemophilus) vaginalis.

Authors:  P Piot; E Van Dyck; P A Totten; K K Holmes
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

5.  In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.

Authors:  M Peeters; E Van Dyck; P Piot
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

6.  Susceptibility of Chlamydia trachomatis to antibiotics in vitro and in vivo.

Authors:  G Johannisson; A Sernryd; E Lycke
Journal:  Sex Transm Dis       Date:  1979 Apr-Jun       Impact factor: 2.830

7.  Epidemiology and therapy of Chlamydia trachomatis infections.

Authors:  W R Bowie
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

8.  In vitro and in vivo efficacy of antimicrobials against Chlamydia trachomatis.

Authors:  W R Bowie
Journal:  Infection       Date:  1982       Impact factor: 3.553

9.  In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors:  R Wise; J M Andrews; L J Edwards
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

10.  Cultivation of Chlamydia trachomatis in cycloheximide-treated mccoy cells.

Authors:  K T Ripa; P A Mårdh
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

  10 in total
  8 in total

Review 1.  Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects.

Authors:  D C Hooper; J S Wolfson
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 2.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

3.  Ofloxacin. Therapeutic results in Chlamydia trachomatis genital infection.

Authors:  M Nedeljkovic; S Djukic
Journal:  Drugs       Date:  1995       Impact factor: 9.546

4.  In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains.

Authors:  H Maeda; A Fujii; K Nakata; S Arakawa; S Kamidono
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

Review 5.  Quinolones in sexually transmitted diseases.

Authors:  G L Ridgway
Journal:  Drugs       Date:  1993       Impact factor: 9.546

6.  Comparative efficacies of ofloxacin, cefotaxime, and doxycycline for treatment of experimental epididymitis due to Escherichia coli in rats.

Authors:  E Vieler; C Jantos; H L Schmidts; W Weidner; H G Schiefer
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

7.  Effects of quinolone analog CI-960 in a monkey model of Chlamydia trachomatis salpingitis.

Authors:  D L Patton; Y T Cosgrove; C C Kuo; L A Campbell
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

8.  In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.

Authors:  A Nagayama; T Nakao; H Taen
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.